AstraZeneca · 13 hours ago
US Medical Affairs - GI Oncology Summer Intern (Doctoral)
Gaithersburg, MD
Internship
Hybrid
Intern
$40/hr - $48/hrAstraZeneca is seeking PhD and PharmD students for a 12-week internship role in Gaithersburg, MD. The role involves analyzing medical insights, developing scientific materials for medical education, and enhancing medical affairs efficiency within the Oncology GI team.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
No H1B
Responsibilities
Analyze and synthesize medical insights from multiple sources to inform medical strategy and tactics
Develop external-facing scientific materials to support ongoing medical education efforts
Explore internal technologies to enhance medical affairs efficiency and impact within the USMA- Oncology GI team
Qualification
Required
PhD and PharmD students studying life sciences and/or pharmaceuticals
Strong scientific background is required
Candidates must have an expected graduation date after August 2026
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3 days per week
Preferred
Analytical and presentation skills are preferred
Prior oncology research experience is a plus
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
Benefits
401(k) plan
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Founded in 1999
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Pascal Soriot
Executive Director and Chief Executive Officer
Aradhana Sarin
Group CFO and Executive Director
Recent News
Essential Business
2026-01-24
2026-01-23
Company data provided by crunchbase